查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786996

Dupixent市场，规模，占有率，趋势，产业分析报告:各适应症，各流通管道，各地区-2025年～2034年市场预测

Dupixent Market Size, Share, Trends, Industry Analysis Report By Indication [Atopic Dermatitis (AD), Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)], By Distribution Channel, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球 Dupixent 市场规模将达到 287 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

Dupixent 市场指的是 dupilumab（一种针对 2 型发炎相关特定蛋白质的生物药物）的全球商业格局。该市场涵盖 dupilumab 的各个环节，从研发到生产、分销、销售，最终到患者使用。 Dupixent 是一种处方药，主要用于治疗多种慢性发炎性疾病，包括中度至重度异位性皮肤炎、气喘、伴随鼻息肉的慢性鼻窦炎、嗜酸性食道炎、结节性痒疹以及一种慢性阻塞性肺病。该市场涵盖整个价值链，包括製药公司、医疗保健提供者以及受益于这种先进疗法的患者。

Dupixent 市场正在经历显着的成长和演变，这得益于人们对 2 型发炎的理解日益加深，以及治疗相关慢性疾病的巨大未满足需求。 Dupixent 最初获准用于治疗异位性皮肤炎，此后已获准用于多种适应症和年龄组，显着扩展了其市场，并使其成为一种用途广泛的治疗选择。 Dupixent 的作用机制是抑制白细胞介素 4 (IL-4) 和白细胞介素 13 (IL-13) 通路中的信号传导，这使其有别于传统疗法，并提供了一种针对性的方法来解决这些复杂的疾病。这使得 Dupixent 获得了处方医生和患者的广泛认可，巩固了其在全球医药市场的地位。

Dupixent 市场报告重点

按适应症划分，异位性皮肤炎 (AD) 将在 2024 年占最大的市场占有率。异位性皮肤炎发病率普遍较高，Dupixent 在治疗中度至重度异位性皮肤炎方面已得到证实的疗效，确保了其在市场上的领先地位和持续的需求。

依分销管道划分，2024年医院药局占了Dupixent分销的最大占有率。这主要是因为Dupixent是一种特殊的生物製剂，通常需要在院内进行初始给药和密切监测，这使得医务人员能够更好地管理其独特的处理方式和病患教育需求。

依地区划分，北美是Dupixent市场的领导者。这项优势得益于其先进的医疗基础设施、对创新生物製剂的高度认知和接受度、优惠的报销政策以及大量的2型发炎疾病患者。亚太地区正迅速崛起，成为一个充满活力、高成长的市场。这一增长受到多种因素的推动，包括医疗基础设施的改善、可支配收入的增加以及人们对慢性发炎疾病先进治疗方案的认识不断提高。

赛诺菲和再生元是Dupixent市场的领导公司。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 Dupixent的全球市场的洞察

  • 市场概述
  • Dupixent市场动态
  • 开发平台分析
  • 市场集中度与特征
    • 促进因素和机会
      • 2 型发炎性疾病盛行率不断上升
      • 获准适应症和年龄层的扩大
    • 限制因素和挑战
      • 治疗成本高
  • PESTEL分析
  • Dupixent市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球Dupixent市场:各适应症

  • 主要调查结果
  • 简介
  • 异位性皮肤炎(AD)
  • 气喘
  • 伴随鼻息肉的慢性鼻窦炎(CRSwNP)
  • 慢性阻塞性肺病（COPD）
  • 其他

第6章 全球Dupixent市场:各流通管道

  • 主要调查结果
  • 简介
  • 医院药局
  • 零售药局
  • 其他

第7章 全球Dupixent市场:各地区

  • 主要调查结果
  • 简介
    • Dupixent市场评估:地区，2020年～2034年
  • 北美
    • 北美:各适应症，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各适应症，2020年～2034年
    • 欧洲:各流通管道，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各适应症，2020年～2034年
    • 亚太地区:各流通管道，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各适应症，2020年～2034年
    • 中东·非洲:各流通管道，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:征兆，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Regeneron Pharmaceuticals
  • Sanofi
Product Code: PM5988

The global dupixent market size is expected to reach USD 28.70 billion by 2034, according to a new study by Polaris Market Research. The report "Dupixent Market Size, Share, Trends, Industry Analysis Report By Indication [Atopic Dermatitis (AD), Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)], By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Dupixent market refers to the global commercial landscape for dupilumab, a biologic medication that targets specific proteins involved in type 2 inflammation. This market includes all aspects from the research and development of dupilumab to its manufacturing, distribution, and sale, and ultimately its use by patients. Dupixent is a prescription-only medication primarily used to treat a range of chronic inflammatory conditions, including moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and a specific type of chronic obstructive pulmonary disease. The market encompasses the entire value chain, involving pharmaceutical companies, healthcare providers, and the patients who benefit from this advanced therapy.

The Dupixent market has seen considerable growth and evolution, driven by the increasing understanding of type 2 inflammation and the significant unmet needs in treating associated chronic diseases. Initially approved for atopic dermatitis, Dupixent's market expansion has been greatly influenced by its subsequent regulatory approvals across various indications and age groups, making it a versatile treatment option. Its mechanism of action, which involves inhibiting the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways, differentiates it from traditional treatments and offers a targeted approach to managing these complex conditions. This has led to strong adoption among both prescribers and patients, contributing to its substantial presence in the global pharmaceutical landscape.

Dupixent Market Report Highlights

By indication, the atopic dermatitis (AD) segment held the largest share in 2024. Its widespread prevalence and Dupixent's established efficacy in treating moderate-to-severe forms of this chronic skin condition have ensured its leading position and continued demand within the market.

By distribution channel, the hospital pharmacies segment held the largest share in 2024 in Dupixent distribution. This is primarily because Dupixent, as a specialized biologic, often requires initial administration or close monitoring in a hospital setting, where healthcare professionals are equipped to manage its specific handling and patient education needs.

By region, North America is leading in the Dupixent market. This dominance is driven by its advanced healthcare infrastructure, high awareness and acceptance of innovative biologic therapies, favorable reimbursement policies, and a significant patient population suffering from type 2 inflammatory diseases. Asia Pacific is rapidly emerging as a dynamic and high-growth region for the market. This growth is propelled by several factors, including improving healthcare infrastructure, rising disposable incomes, and increasing awareness of advanced treatment options for chronic inflammatory diseases.

Key players in the market include Sanofi and Regeneron Pharmaceuticals.

Polaris Market Research has segmented the Dupixent market report based on indication, distribution channel, and region:

By Indication Outlook (Revenue - USD Billion, 2020-2034)

Atopic Dermatitis (AD)

Asthma

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Chronic Obstructive Pulmonary Disease (COPD)

Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dupixent Market Insights

  • 4.1. Dupixent Market - Market Snapshot
  • 4.2. Dupixent Market Dynamics
  • 4.3. Pipeline Analysis
  • 4.4. Market Concentration & Characteristics
    • 4.4.1. Drivers and Opportunities
      • 4.4.1.1. Rising Prevalence of Type 2 Inflammatory Diseases
      • 4.4.1.2. Broadening of Approved Indications and Age Groups
    • 4.4.2. Restraints and Challenges
      • 4.4.2.1. High treatment costs
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers (Moderate)
    • 4.5.2. Threats of New Entrants: (Low)
    • 4.5.3. Bargaining Power of Buyers (Moderate)
    • 4.5.4. Threat of Substitute (Moderate)
    • 4.5.5. Rivalry among existing firms (High)
  • 4.6. PESTEL Analysis
  • 4.7. Dupixent Market Trends
  • 4.8. Value Chain Analysis
  • 4.9. COVID-19 Impact Analysis

5. Global Dupixent Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • 5.3. Atopic Dermatitis (AD)
    • 5.3.1. Global Dupixent Market, by Atopic Dermatitis (AD), by Region, 2020-2034 (USD Billion)
  • 5.4. Asthma
    • 5.4.1. Global Dupixent Market, by Asthma, by Region, 2020-2034 (USD Billion)
  • 5.5. Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
    • 5.5.1. Global Dupixent Market, by Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), by Region, 2020-2034 (USD Billion)
  • 5.6. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.6.1. Global Dupixent Market, by Chronic Obstructive Pulmonary Disease (COPD), by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dupixent Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dupixent Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Dupixent Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Dupixent Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Dupixent Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Dupixent Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Dupixent Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Dupixent Market - North America
    • 7.3.1. North America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.2. North America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.3.3. Dupixent Market - U.S.
      • 7.3.3.1. U.S.: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.3.4. Dupixent Market - Canada
      • 7.3.4.1. Canada: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4. Dupixent Market - Europe
    • 7.4.1. Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.3. Dupixent Market - UK
      • 7.4.3.1. UK: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.4. Dupixent Market - France
      • 7.4.4.1. France: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.5. Dupixent Market - Germany
      • 7.4.5.1. Germany: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.6. Dupixent Market - Italy
      • 7.4.6.1. Italy: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.7. Dupixent Market - Spain
      • 7.4.7.1. Spain: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.8. Dupixent Market - Netherlands
      • 7.4.8.1. Netherlands: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.9. Dupixent Market - Russia
      • 7.4.9.1. Russia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.10. Dupixent Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5. Dupixent Market - Asia Pacific
    • 7.5.1. Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.3. Dupixent Market - China
      • 7.5.3.1. China: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.4. Dupixent Market - India
      • 7.5.4.1. India: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.5. Dupixent Market - Malaysia
      • 7.5.5.1. Malaysia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.6. Dupixent Market - Japan
      • 7.5.6.1. Japan: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.7. Dupixent Market - Indonesia
      • 7.5.7.1. Indonesia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.8. Dupixent Market - South Korea
      • 7.5.8.1. South Korea: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.9. Dupixent Market - Australia
      • 7.5.9.1. Australia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.10. Dupixent Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6. Dupixent Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.3. Dupixent Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.4. Dupixent Market - UAE
      • 7.6.4.1. UAE: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.5. Dupixent Market - Israel
      • 7.6.5.1. Israel: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.6. Dupixent Market - South Africa
      • 7.6.6.1. South Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.7. Dupixent Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7. Dupixent Market - Latin America
    • 7.7.1. Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.3. Dupixent Market - Mexico
      • 7.7.3.1. Mexico: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.4. Dupixent Market - Brazil
      • 7.7.4.1. Brazil: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.5. Dupixent Market - Argentina
      • 7.7.5.1. Argentina: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.6. Dupixent Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Regeneron Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Sanofi
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development

List of Tables:

  • Table 1 Global Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 2 Global Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 3 North America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 4 North America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 U.S.: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 6 U.S.: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 Canada: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 8 Canada: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 10 Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 11 UK: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 UK: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 France: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 14 France: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 Germany: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 16 Germany: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 17 Italy: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 18 Italy: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 Spain: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 20 Spain: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 23 Russia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 Russia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 29 China: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 30 China: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 India: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 32 India: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 35 Japan: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Japan: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 39 South Korea: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 40 South Korea: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 41 Australia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 42 Australia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 UAE: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 50 UAE: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Israel: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 52 Israel: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 53 South Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 54 South Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 58 Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 59 Mexico: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 Mexico: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Brazil: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 62 Brazil: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 63 Argentina: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 64 Argentina: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Dupixent Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Indication
  • Figure 7. Global Dupixent Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Dupixent Market, by Distribution Channel, 2024 & 2034 (USD Billion)